PL3145522T3 - Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom - Google Patents

Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom

Info

Publication number
PL3145522T3
PL3145522T3 PL15727805T PL15727805T PL3145522T3 PL 3145522 T3 PL3145522 T3 PL 3145522T3 PL 15727805 T PL15727805 T PL 15727805T PL 15727805 T PL15727805 T PL 15727805T PL 3145522 T3 PL3145522 T3 PL 3145522T3
Authority
PL
Poland
Prior art keywords
composition
combination
animals
administering
Prior art date
Application number
PL15727805T
Other languages
English (en)
Inventor
Kenneth W. Bafundo
A. Bruce Johnson
David CALABOTTA
Wendell KNEHANS
Original Assignee
Phibro Animal Health Corporation
Desert King International Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phibro Animal Health Corporation, Desert King International Llc filed Critical Phibro Animal Health Corporation
Publication of PL3145522T3 publication Critical patent/PL3145522T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL15727805T 2014-05-23 2015-05-22 Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom PL3145522T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462002527P 2014-05-23 2014-05-23
PCT/US2015/032301 WO2015179840A1 (en) 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals
EP15727805.2A EP3145522B1 (en) 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals

Publications (1)

Publication Number Publication Date
PL3145522T3 true PL3145522T3 (pl) 2021-06-14

Family

ID=53366304

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15727805T PL3145522T3 (pl) 2014-05-23 2015-05-22 Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom

Country Status (18)

Country Link
US (4) US10413581B2 (pl)
EP (1) EP3145522B1 (pl)
JP (2) JP6869177B2 (pl)
KR (1) KR20170008850A (pl)
CN (1) CN106659787A (pl)
AU (2) AU2015263877B2 (pl)
BR (1) BR112016027335B1 (pl)
CA (1) CA2949965A1 (pl)
CL (1) CL2016002992A1 (pl)
ES (1) ES2856207T3 (pl)
IL (1) IL249061B (pl)
MX (1) MX381845B (pl)
MY (1) MY181854A (pl)
PH (1) PH12016502323A1 (pl)
PL (1) PL3145522T3 (pl)
RU (1) RU2707076C2 (pl)
WO (1) WO2015179840A1 (pl)
ZA (1) ZA201608077B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6045895B2 (ja) 2012-10-01 2016-12-14 株式会社トプコン 眼科観察装置
US11238056B2 (en) 2013-10-28 2022-02-01 Microsoft Technology Licensing, Llc Enhancing search results with social labels
US11645289B2 (en) 2014-02-04 2023-05-09 Microsoft Technology Licensing, Llc Ranking enterprise graph queries
DK3110437T3 (en) 2014-02-12 2018-01-22 Omnigen Res Llc COMPOSITION AND PROCEDURE FOR PROMOTING REDUCTION OF HEAT Stress FOR ANIMALS
US9870432B2 (en) 2014-02-24 2018-01-16 Microsoft Technology Licensing, Llc Persisted enterprise graph queries
US11657060B2 (en) 2014-02-27 2023-05-23 Microsoft Technology Licensing, Llc Utilizing interactivity signals to generate relationships and promote content
US10757201B2 (en) 2014-03-01 2020-08-25 Microsoft Technology Licensing, Llc Document and content feed
US10169457B2 (en) 2014-03-03 2019-01-01 Microsoft Technology Licensing, Llc Displaying and posting aggregated social activity on a piece of enterprise content
US10255563B2 (en) 2014-03-03 2019-04-09 Microsoft Technology Licensing, Llc Aggregating enterprise graph content around user-generated topics
US10394827B2 (en) 2014-03-03 2019-08-27 Microsoft Technology Licensing, Llc Discovering enterprise content based on implicit and explicit signals
WO2015179840A1 (en) 2014-05-23 2015-11-26 Phibro Animal Health Corporation Combination, composition, and method of administering the combination or composition to animals
US10061826B2 (en) * 2014-09-05 2018-08-28 Microsoft Technology Licensing, Llc. Distant content discovery
WO2017044832A1 (en) 2015-09-09 2017-03-16 Omnigen Research, Llc A composition and/or combination for aquaculture
CA2972175C (en) 2016-07-29 2022-03-01 Trinidad Schlotterbeck Suarez Use of quillaja saponaria extracts for the prevention and control of bacterial infections in fish
CA2972174C (en) 2016-07-29 2022-01-11 Saponin Research Center S.A. Use of quillaja saponaria extracts for the prevention and control of viral infections in fish
CA3061236A1 (en) 2017-05-22 2018-11-29 F. Hoffmann-La Roche Ag Therapeutic compounds and compositions, and methods of use thereof
CN107535727A (zh) * 2017-10-29 2018-01-05 镇江龙润生态农业发展有限公司 一种含有中草药的用于肉鸡无抗生态养殖的饲料添加剂
WO2019147799A1 (en) * 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用
JP2023531395A (ja) * 2020-06-19 2023-07-24 キンバリー クラーク ワールドワイド インコーポレイテッド 非ヒト動物の治療において有用なヘスペラロエから調製した抽出物を含むサポニン
CN115916216A (zh) * 2020-06-19 2023-04-04 金伯利-克拉克环球有限公司 用于治疗非人类动物的从草丝兰属制备的含有皂苷的提取物
US20220030913A1 (en) * 2020-08-03 2022-02-03 Hoxie Feedyard, LLC Supplement for livestock
KR102718991B1 (ko) * 2020-09-25 2024-10-16 씨제이제일제당 (주) 스틸벤계 화합물을 포함하는 항콕시듐증 조성물 및 이의 용도
US20240148671A1 (en) * 2021-03-10 2024-05-09 Cornell University Methods for improving poultry health
CN113057141A (zh) * 2021-05-10 2021-07-02 天津农学院 一种提高蛋鸡蛋黄中卵磷脂含量的饲喂方法
ES2932416B2 (es) * 2021-07-07 2023-09-28 Biovet S A Aditivo para animales que contiene saponinas, compuestos fenolicos y p-cimenol, y procedimiento para su obtencion
WO2023163884A1 (en) * 2022-02-22 2023-08-31 Phibro Animal Health Corporation Liquid formulation comprising yucca and quillaja for administration to animals
WO2024156767A1 (en) * 2023-01-25 2024-08-02 Nutreco Nederland B.V. Method of feeding (pre)ruminants
WO2025085377A1 (en) * 2023-10-16 2025-04-24 Zoetis Services Llc Use of zoalene in livestock

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07107923A (ja) 1993-10-13 1995-04-25 Taiyo Kagaku Co Ltd 飼料用組成物
JP3422834B2 (ja) * 1994-02-09 2003-06-30 日本農産工業株式会社 飼料添加剤
JP3623994B2 (ja) 1994-11-05 2005-02-23 太陽化学株式会社 甲殻類の感染症抑制飼料組成物
CA2197751A1 (en) 1996-02-26 1997-08-27 F. Hoffmann-La Roche Ag Growth promotion in chickens
TWI223595B (en) 1999-09-07 2004-11-11 Distributors Proc Inc Steroidal sapogenins for the control of coccidiosis in animals
DE19952360A1 (de) 1999-10-30 2001-05-17 Becker Klaus Wolfgang Verwendung von Saponinen und/oder Saponin-Derivaten als Wirkstoff bei der Aufzucht und Mast von Fischen und Krustentieren, deren Einsatz als Futtermittelzusatz sowie Futtermittel, enthaltend diese Futtermittelzusätze
JP4499355B2 (ja) * 2001-01-08 2010-07-07 パスウェイ・インターミディエイツ・リミテッド 自己誘導因子化合物およびその使用
US20040096527A1 (en) * 2001-02-27 2004-05-20 Jin-Hyuck Jang Compositions for lowering serum cholesterol level
ZA200400479B (en) 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
JP2005532405A (ja) * 2002-07-10 2005-10-27 アクゾ・ノベル・エヌ・ベー 融合タンパク質とサポニンアジュバントとを含む免疫原性組成物
US7416742B2 (en) * 2004-06-16 2008-08-26 Sartec Corporation Methods and compositions for controlling microorganism populations in the digestive system of animals
CN101563090B (zh) * 2006-11-20 2013-01-02 杜科姆公司 包含南美皂皮树皂苷的含脂质颗粒用于治疗癌症的用途
TW201010719A (en) * 2008-08-19 2010-03-16 Wyeth Corp Immunological composition
US20100150958A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. Methods and Compositions for Use of a Coccidiosis Vaccine
ES2386474B1 (es) * 2011-01-21 2013-07-09 Norel, Sa Aditivos para alimentación animal.
WO2015179840A1 (en) * 2014-05-23 2015-11-26 Phibro Animal Health Corporation Combination, composition, and method of administering the combination or composition to animals
WO2019147799A1 (en) * 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals

Also Published As

Publication number Publication date
US20190350998A1 (en) 2019-11-21
RU2707076C2 (ru) 2019-11-22
US10413581B2 (en) 2019-09-17
PH12016502323A1 (en) 2017-02-06
JP2017517570A (ja) 2017-06-29
MY181854A (en) 2021-01-11
JP2020090502A (ja) 2020-06-11
IL249061A0 (en) 2017-01-31
US20170072002A1 (en) 2017-03-16
MX2016015326A (es) 2017-05-30
WO2015179840A1 (en) 2015-11-26
CN106659787A (zh) 2017-05-10
IL249061B (en) 2020-05-31
CA2949965A1 (en) 2015-11-26
AU2021202307B2 (en) 2022-06-30
AU2015263877B2 (en) 2021-01-21
MX381845B (es) 2025-03-13
BR112016027335B1 (pt) 2021-06-08
RU2016149801A3 (pl) 2018-11-14
US12201666B2 (en) 2025-01-21
JP6869177B2 (ja) 2021-05-12
AU2021202307A1 (en) 2021-05-13
ES2856207T3 (es) 2021-09-27
US20250152654A1 (en) 2025-05-15
AU2015263877A1 (en) 2017-01-12
EP3145522A1 (en) 2017-03-29
RU2016149801A (ru) 2018-06-25
ZA201608077B (en) 2020-01-29
CL2016002992A1 (es) 2017-05-19
US20210113647A1 (en) 2021-04-22
US10912810B2 (en) 2021-02-09
KR20170008850A (ko) 2017-01-24
EP3145522B1 (en) 2020-12-23

Similar Documents

Publication Publication Date Title
PL3145522T3 (pl) Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom
KR20180084891A (ko) 구조 조성물 및 방법
IL248519A0 (en) Bioceramic compositions and biomodulatory uses thereof
HUE052095T2 (hu) Keratin kezelési készítmények és eljárások
LT3206497T (lt) Kompozicijos ir būdai, skirti meibomo liaukos disfunkcijos gydymui
DK3104718T3 (da) Tobaksholdig gelsammensætning
PL3277270T3 (pl) Kompozycje i sposoby leczenia niedokrwistości
IL257784A (en) Pharmaceutical composition used for reducing localised fat and use of pharmaceutical composition
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
MA41794A (fr) Agents thérapeutiques modifiés et compositions associées
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
PL3154515T3 (pl) Udoskonalenia kompozycji donosowych i sposób ich stosowania
BR112016026143A2 (pt) os métodos e composições compreendendo ácido 10-hidroxi-2-decenóico.
PL3145592T3 (pl) Kompozycja do pielęgnacji skóry
PL3250042T3 (pl) Kompozycja, sposób, zastosowanie i wyrób
PL3373922T3 (pl) Kompozycje i sposoby do stosowania do leczenia homocystynurii
EP3417845A4 (en) ALPHA FORMULATION COMPOSITION AND ALPHA YELLOW COMPOSITION
LT3229790T (lt) Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme
BR112017013928A2 (pt) composição alimentar e método de uso.
IL252191B (en) Compositions and methods for modulating at2r activity
EP3305309A4 (en) ANTICARIOGENIC AGENT AND ANTICARIAC COMPOSITION
DK3233104T3 (da) Immunterapi-behandlinger og -sammensætninger
IL252707A0 (en) Compositions and methods for treating diseases and conditions
PL3191080T3 (pl) Kompozycje pozajelitowe i ich zastosowanie